Your email has been successfully added to our mailing list.

×
-0.0199999999999999 -0.0199999999999999 -0.034 -0.04 -0.0299999999999999 -0.0299999999999999 -0.024 -0.0169599999999999
Stock impact report

Chairman’s Address to the Mesoblast 2017 Annual General Meeting

Mesoblast Limited - American Depositary Shares (MESO) 
US:NASDAQ Investor Relations: investorsmedia.mesoblast.com
Company Research Source: GlobeNewswire
MELBOURNE, Australia and NEW YORK, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Welcome to the Mesoblast 2017 Annual General Meeting. It has been a significant year for Mesoblast. Our proprietary and leading-edge cell therapy technology platform has demonstrated consistent and durable clinical outcomes across multiple difficult-to-treat diseases where we believe our technology offers unique benefits and could achieve commercial blockbuster potential. Our three most advanced product candidates are fast approaching major Phase 3 outcomes, bringing our goal of commercializing cellular medicines close to fruition. We look forward to reporting shortly on the Phase 3 results of our cell therapy for the most devastating complication of bone marrow transplants in children with blood cancers. This product candidate is well poised to become the first industrially manufactured allogeneic cellular medicine commercially available in the United States, extending on the success of our technology platform Show less Read more
Impact Snapshot
Event Time:
MESO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MESO alerts
Opt-in for
MESO alerts

from News Quantified
Opt-in for
MESO alerts

from News Quantified